Featured Articles:

FCPA Corporate Leniency: A Good Try But the Wrong Idea

FCPA Corporate Leniency: A Good Try But the Wrong Idea

H.L. Mencken The kind of man who wants government to adopt and enforce his ideas is always the kind of man whose ideas are idiotic – H. L. Mencken As the House Judiciary Committee gets ready to hold an FCPA oversight hearing, I thought it would be timely to examine one of the more significant FCPA reform proposals Robert W. Tarun and Peter P. Tomczak,...

Voluntary Disclosures and Whistleblowers: A New Dynamic

Voluntary Disclosures and Whistleblowers: A New Dynamic

With the new SEC whistleblower rules, companies now face a difficult decision of whether and when to disclose to the SEC and DOJ potential FCPA violations. The issue is not new but the dynamic will certainly be different. For example, when it is clear that whistleblower intends to report allegations to the SEC, the company needs to consider whether to make a pre-emptive report to...

Immunizing Your Third-Party Agent Due Diligence Process from Prosecution

Immunizing Your Third-Party Agent Due Diligence Process from Prosecution

FCPA websites and blogs are filled with company advertisements offering due diligence services, guaranteeing facts and results. But this is only one piece in the due diligence puzzle and process. Designing a review protocol, ensuring that information is gathered and reviewed, and most importantly, requiring a brief memo reflecting the review and decision-making process, along with a statement of reasons for approving a third party,...

HHS’ Power of Exclusion: Guilt by Association

HHS’ Power of Exclusion: Guilt by Association

The Department of Health and Human Services’ Office of Inspector General (HHS OIG) is flexing its muscle these days – on Aprill 12, 2011, the OIG notified Howard Solomon, the long-time CEO and Chairman of Forest Laboratories, a manufacturer of antidepressant pharmaceuticals, that it was contemplating proceedings to exclude him from all federal health care programs. The notification came in the wake of Forest Laboratories’...

The Next Step in FCPA Enforcement – Wiretaps in the Boardroom

The Next Step in FCPA Enforcement – Wiretaps in the Boardroom

The headlines these days focus on the SEC whistleblower rules and the implications for corporations.  While the whistleblower rules are important and justify vigilant compliance efforts, there is a more significant, and possibly damaging, trend for FCPA enforcement. Corporations now have to consider the risk that the government will conduct wiretaps of target telephones.  In the Shot Show sting, the government demonstrated it was willing...

The Next Step in FCPA Enforcement – Wiretaps in the Boardroom

The Next Step in FCPA Enforcement – Wiretaps in the Boardroom

The headlines these days focus on the SEC whistleblower rules and the implications for corporations.  While the whistleblower rules are important and justify vigilant compliance efforts, there is a more significant, and possibly damaging, trend for FCPA enforcement. Corporations now have to consider the risk that the government will conduct wiretaps of target telephones.  In the Shot Show sting, the government demonstrated it was willing...

The Next Step in FCPA Enforcement – Wiretaps in the Boardroom

The Next Step in FCPA Enforcement – Wiretaps in the Boardroom

The headlines these days focus on the SEC whistleblower rules and the implications for corporations.  While the whistleblower rules are important and justify vigilant compliance efforts, there is a more significant, and possibly damaging, trend for FCPA enforcement. Corporations now have to consider the risk that the government will conduct wiretaps of target telephones.  In the Shot Show sting, the government demonstrated it was willing...

The Real Impact of the SEC’s New Whistleblower Program

The Real Impact of the SEC’s New Whistleblower Program

When you consider that over 90 percent of the Justice Department’s prosecutions of corporations originate from voluntary disclosures, as opposed to proactive investigative steps, you know there is something wrong with this picture. For the foreseeable future, the Justice Department is happy just to sit and take confessions from companies who believe that voluntary disclosure is the best course to follow. The equation is about...

Health Care Reform and Competition

Health Care Reform and Competition

In the year since the Patient Protection and Affordable Care Act (PPACA) has been enacted, the industry has been wrestling with new mandates, incentives and compliance issues. Of course, there is a lot at stake – Medicare reimbursements in the billions of dollars. In many areas, health care organizations have to determine how they can collaborate with other institutions to reduce costs and gain efficiencies...

Health Care Reform and Competition

Health Care Reform and Competition

In the year since the Patient Protection and Affordable Care Act (PPACA) has been enacted, the industry has been wrestling with new mandates, incentives and compliance issues. Of course, there is a lot at stake – Medicare reimbursements in the billions of dollars. In many areas, health care organizations have to determine how they can collaborate with other institutions to reduce costs and gain efficiencies...